Wei Wang

Wei Wang

Auto-generated profile, based on publicly available information

Wei Wang

Department of Pathology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2023 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
ZYZengpanpan Ye
Zengpanpan Ye
XAXiaolin Ai
Xiaolin Ai
KYKailin Yang
Kailin Yang
ZYZhengnan Yang
Zhengnan Yang
FFFan Fei
Fan Fei
SZShengtao Zhou
Shengtao Zhou
Glioblastoma (GBM) constitutes the most lethal primary brain tumor for which immunotherapy has provided limited benefit. The unique brain immune landscape is reflected in a complex tumor immune microenvironment (TIME) in GBM. Here, single-cell sequencing of the GBM TIME revealed that microglia were under severe oxidative stress, which induced nuclear receptor subfamily 4 group A member 2 (NR4A2)–dependent transcriptional activity in microglia. Heterozygous Nr4a2 (Nr4a2+/−) or CX3CR1+ myeloid cell–specific Nr4a2 (Nr4a2fl/flCx3cr1Cre) genetic targeting reshaped microglia plasticity in vivo by reducing alternatively activated microglia and enhancing antigen presentation capacity for CD8+ T cells in GBM. In microglia, NR4A2 activated squalene monooxygenase (SQLE) to dysregulate cholesterol homeostasis. Pharmacologic NR4A2 inhibition attenuated the protumorigenic TIME, and targeting the NR4A2 or SQLE enhanced the therapeutic efficacy of immune-checkpoint blockade in vivo. Collectively, oxidative stress promotes tumor growth through NR4A2–SQLE activity in microglia, informing novel immune therapy paradigms in brain cancer. Significance: Metabolic reprogramming of microglia in GBM informs synergistic vulnerabilities for immune-checkpoint blockade therapy in this immunologically cold brain tumor. This article is highlighted in the In This Issue feature, p. 799

26 February 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
ZYZhengnan Yang
Zhengnan Yang
WWWei Wang
Wei Wang
LZLinjie Zhao
Linjie Zhao
XWXin Wang
Xin Wang
RGRyan C. Gimple
Ryan C. Gimple
SZShengtao Zhou
Shengtao Zhou
Plasma cells shape the mesenchymal identity of ovarian cancers through exosome-mediated miR-330-3p/JAM2 axis.

26 March 2025 in Gut
Verified
Journal Article
Closed access
PDF file
HXHonghai Xu
Honghai Xu
ZWZihao Wu
Zihao Wu
JQJiangfeng Qin
Jiangfeng Qin
XLXutong Li
Xutong Li
FXFeng Xu
Feng Xu
Hua WangHua Wang
Hua Wang
Background: Neutrophil infiltration and hepatocyte damage are indispensable hallmarks in alcohol-associated hepatitis (AH), yet the underlying crosstalk between neutrophils and hepatocytes and its role in AH pathogenesis remain unclear. Objective: We investigate the regulatory role of leucocyte cell-derived chemotaxin 2 (LECT2) in hepatocyte–neutrophil interaction and its impact on AH progression. Design: We used bulk and single-cell RNA sequencing to identify hepatocyte-secreted factors targeting neutrophils. We analysed serum and liver samples from AH patients and employed genetically modified mice alongside in vitro studies. Results: RNA-sequencing analysis identified several neutrophil chemokines that are elevated in hepatocytes from AH patients, including LECT2 whose role in AH remains largely unknown. AH patients exhibited increased levels of LECT2 in hepatocytes, positively correlating with the severity of AH. Ethanol-fed mice also exhibited elevated liver LECT2, which was abolished by inhibiting endoplasmic reticulum stress. Functional studies revealed that ethanol-induced liver injury was ameliorated in Lect2 -deficient mice but was exacerbated in mice with hepatic overexpression of Lect2 . Furthermore, LECT2 exacerbated ethanol-induced liver injury by promoting reactive oxygen species (ROS) through its interaction with prohibitin 2 (PHB2), a neutrophil membrane protein. By directly binding to PHB2, LECT2 disrupts the stable structure of PHB1/PHB2 heterodimerisation, consequently leading to PHB2 degradation, ROS accumulation, neutrophil activation and neutrophil extracellular trap formation. Moreover, therapeutic intervention of LECT2 via Lect2 shRNA ameliorated ethanol-induced liver injury. Conclusion: Our studies identified a novel vicious cycle between neutrophils and hepatocytes through the LECT2–PHB2 interaction, presenting a promising therapeutic intervention by targeting LECT2 to mitigate AH in patients.

1 January 2022 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
HGHaiyan Gu
Haiyan Gu
WWWei Wang
Wei Wang
CSChangdong Sun
Changdong Sun
LDLi Ding
Li Ding
LLLi Li
Li Li
JXJun Xu
Jun Xu
Although metastasis is the major cause of death in cervical cancer, the mechanism of metastasis is still unclear. The mRNA expression and protein level of latent transforming growth factor beta binding protein 1 (LTBP1) were detected in tumor tissues and paracancerous tissues from in-house samples. Cell proliferation, cell cycle, migration, and in vivo metastasis were determined after LTBP1 was knocked down. Then, 13 drugs were screened, and the changes in cell apoptosis and proliferation and tumor metastasis were detected after drug treatment in shRNA cells. In our in-house samples, LTBP1 was lowly expressed in cervical cancer tissues. After LTBP1 knockdown, cell proliferation was increased, and the ability of in vitro migration and in vivo metastasis was enhanced. At the same time, the proportion of myeloid derived suppressor cells (MDSC) in situ increased, the proportion of T cells decreased, and transforming growth factor beta-1 (TGFβ1) signaling was activated. After carboplatin treatment, LTBP1 shRNA cell line apoptosis increased, metastasis in vivo was limited, and the proportion of MDSC in situ decreased. LTBP1 was lowly expressed in cervical cancer, and the inhibition of LTBP1 can improve the malignant degree of the tumor, and this process can be blocked by carboplatin.

24 November 2025 in Hepatology Communications
Verified
Journal Article
Open access
HZHui Zhang
Hui Zhang
WWWei Wang
Wei Wang
YGYufeng Gao
Yufeng Gao
YQYuting Qian
Yuting Qian
WXWen Xu
Wen Xu
HXHonghai xu
Honghai xu
Background: Liver regeneration is a highly complex biological process, and the molecular mechanisms governing regenerative capacity exhibit significant divergence across distinct developmental stages. This study aimed to developmentally conserve pro-regenerative regulators of the liver and elucidate their mechanistic roles in the developmental stages of liver regeneration. Methods: Wild-type mice at distinct developmental stages, including 1-month-old (adolescent), 4-month-old (adult), 12-month-old (middle-aged), and 20-month-old (aged), underwent sham surgery or 2/3 partial hepatectomy. RNA sequencing and scRNA-seq identified the target gene and spatial expression. Hepatocyte proliferation was assessed by Ki-67, PCNA staining, and hematoxylin and eosin staining. Functional and mechanistic studies have employed bioinformatics, IF, coimmunoprecipitation, quantitative real-time PCR, and small-molecule inhibition. Results: RNA sequencing across age groups identified leukocyte cell–derived chemotaxin 2 (LECT2) as a functionally significant mediator in liver regeneration processes. Longitudinal assessment of murine liver regeneration models and patients who underwent hepatectomy revealed dynamic LECT2 expression patterns. LECT2 expression positively correlated with regeneration markers Ki-67 and PCNA. Lect2 -KO mice in 4 age groups exhibited impaired liver regeneration. Immunofluorescence staining and single-cell RNA sequencing demonstrated predominant hepatocyte-specific expression of LECT2. Hepatocyte-specific Lect2 knockout significantly impaired liver regeneration following 2/3 partial hepatectomy. Interestingly, there appeared to be no difference in the level of regeneration in mice with suppressed A Disintegrin and Metalloproteinase Domain 10 (ADAM10) expression despite Lect2 overexpression. Mechanistic investigations revealed that LECT2 potentiates hepatic regeneration by activating the ADAM10-NOTCH signaling pathway. Finally, our in vivo therapeutic model demonstrated that adeno-associated virus–mediated Lect2 overexpression significantly enhanced the posthepatectomy regenerative capacity. Conclusions: LECT2 promotes liver regeneration across developmental stages by activating the ADAM10-NOTCH signaling pathway, providing a promising therapeutic target for enhancing hepatic repair.

7 April 2026 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
NZNianxin Zhou
Nianxin Zhou
FFFan Fei
Fan Fei
LTLin Tang
Lin Tang
PZPeidong Zhang
Peidong Zhang
WWWei Wang
Wei Wang
LZLinjie Zhao
Linjie Zhao
Despite successful immuno-oncology therapies in other cancers, they largely failed in glioblastoma(GBM). Here, natural killer (NK) cells from glioma patients show impaired oxidative phosphorylation and mitochondrial complex I activity. Multiomics profiling identified complex I subunit NDUFA9 as a critical mediator of NK cell metabolic fitness. Abundance of NDUFA9+ NK cells informed patient outcome. Ndufa9 knockout in NK cells compromised mitochondrial function, anti-tumor efficacy, and memory-like phenotype of NK cells by triggering a metabolic reprogramming toward glutamine dependence. Decreased α-ketoglutarate(α-KG)/succinate ratio in Ndufa9-deficient NK cells mediated widespread epigenetic reprogramming through inducing transcriptionally repressive histone mark H3K27me3 on key immune function genes. Resveratrol-mediated NDUFA9 activation or its overexpression enhanced NK cell anti-GBM function by restoring complex I activity. Together, these findings reveal the critical role of mitochondrial complex I activity in NK cells and highlight its potential as an actionable target to enhance NK cell-based immunotherapy for GBM patients.